Loading insider details...
Latest Form 4 (Sep 1, 2026): Grant/Award of 5,000 VRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 5,000 | n/a |
| Mar 2, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 357 | $172.6K |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 546 | $264.9K |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 1,809 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,393 | $679.4K |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 592 | $277.3K |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 2,950 | n/a |
| Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,241 | $595.2K |
| Feb 26, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 828 | $400.2K |
| Feb 19, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 564 | $261.4K |